Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|January 31, 2020
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Science Translational Medicine|June 11, 2025
DeepHeme, a high-performance, generalizable deep ensemble for bone marrow morphometry and hematologic diagnosisShenghuan Sun, Zhanghan Yin, Jacob G Van Cleave, et al.
Blood Advances|October 22, 2025
Prognostic Value of Inflammation-Based Scores in R/R LBCL Patients Treated with CD3xCD20 Bispecific T-Cell EngagersGiulia Magno, Kai Rejeski, Giulia Rappa, et al.
Blood Cancer Journal|August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphomaMichael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.
Blood Advances|September 10, 2021
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCTRoni Shouval, Joshua A Fein, Christina Cho, et al.
Cell|June 9, 2023
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patientsChi L Nguyen, Kate A Markey, Oriana Miltiadous, et al.
European Heart Journal|March 20, 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipientsSyed S Mahmood, Peter A Riedell, Stephanie Feldman, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cellsSarah Staudt, Fabian Nikolka, Markus Perl, et al.
Blood|February 12, 2025
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphomaLaura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.
Pageof 14